Oncology remains a core therapeutic area at AbbVie, featuring a robust portfolio of marketed products and a promising oncology pipeline. AbbVie is currently seeking a dynamic Medical Director / Scientific Director for Medical Affairs, Precision Medicine, to lead U.S. CDx strategy in oncology. This role requires a strong background in diagnostics, pathology, biomarkers, and cancer therapeutics, as well as a demonstrated commitment to precision medicine.

This position must be based at our Mettawa, IL headquarters and will follow a hybrid schedule of 3 days/week in office.

Key Responsibilities

• Lead and deliver a comprehensive, U.S. focused medical strategy for CDx-dependent indications overseeing execution of key deliverables.
• Develop and implement the Medical Affairs strategy for upcoming CDx launches.
• Build and maintain key external relationships with diagnostic partners, academic and community labs, and reference labs.
• Cultivate relationships with expert pathologists and key opinion leaders.
• Forge strong partnerships with leading pathology societies
• Represent Medical Affairs in cross-functional Oncology Precision Medicine teams across the organization.
• Act as the medical affairs lead on the Integrated Brand team and Medical Affairs team.
• Develop and execute a biomarker and CDx evidence generation plan in collaboration with Precision Medicine Development, Health Economics and Outcomes Research, and Therapeutic Area teams.
• Execute key functional deliverables aligned with the CDx medical strategy, including:
  • Evidence generation to address biomarker and testing gaps.
  • Medical review of scientific publications.
  • Educational initiatives for both internal and external audiences on biomarkers and testing.
  • Review of medical promotional materials for biomarker and testing content.
  • Collaboration with Value and Evidence teams on guideline strategies for biomarkers and testing.
  • Insight generation via advisory boards and engagements with external experts.
  • Develop and implement a congress strategy for pathologists, including EE engagements and digital initiatives.
  • Support oncology congresses with biomarker and testing materials in partnership with the Therapeutic Area team.